2023 annual financial data
Cytosorbents 2023 Operating income
Direct answer
Operating income was -31,948,620 USD.
Operating income was -31,948,620 USD and net income was -29,246,760 USD.
Operating cash flow was -21,655,136 USD.
Get free Cytosorbents email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 31,084,953 USD
- Operating income
- -31,948,620 USD
- Net income
- -29,246,760 USD
- Operating cash flow
- -21,655,136 USD